{"disease":{"id":"fms-like-tyrosine-kinase-3-flt3-mutated-acute-myeloid-leukemia","name":"fms like tyrosine kinase 3 flt3 mutated acute myeloid leukemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05219266","title":"Managed Access Programs for PKC412, Midostaurin","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}